Assembly Biosciences's total assets for Q3 2025 were $240.00M, an increase of 197.10% from the previous quarter. ASMB total liabilities were $57.30M for the fiscal quarter, a -8.58% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.